MedPath

Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Management With Medication Abortion Through 70 Days' Gestation

Not Applicable
Completed
Conditions
Abortion in First Trimester
Registration Number
NCT03925129
Lead Sponsor
Planned Parenthood of Greater New York
Brief Summary

This is a double-blinded, randomized, placebo-controlled trial evaluating the use of High-frequency Transcutaneous Electrical Nerve Stimulation (HfTENS) compared to sham TENS for pain control during medication abortion with mifepristone and misoprostol through 70 days' gestation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
40
Inclusion Criteria
  • Patients seeking medication abortion with a definite, singleton, intrauterine pregnancy (IUP) < 70 days' gestation on ultrasound
  • Rapid Estimate of Adult Literacy in Medicine-Short Form (REALM-SF)22 score > 4
  • Age equal to or greater than 18 years
  • Provide informed consent to participate
  • Willing to adhere to study procedures, including access to a smart phone, ability to receive text messages and answer online surveys on smart phone
Exclusion Criteria
  • Contraindication to medication abortion
  • Allergy to mifepristone or misoprostol
  • Contraindication or allergy to ibuprofen
  • History of cardiac arrhythmia
  • Presence of an implantable device with electrical discharge, i.e. cardiac pacemaker
  • History of chronic pain disorder
  • Any opioid use during previous 30 days
  • Current or prior use of TENS
  • BMI > 30

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
Pain on numeric rating scale8 hours following misoprostol

Maximum pain score on an 11-point numeric rating scale, where 0 is no pain, and 10 is the worst pain.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Planned Parenthood of New York City - Margaret Sanger Center

🇺🇸

New York, New York, United States

Planned Parenthood of New York City - Margaret Sanger Center
🇺🇸New York, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.